M. Bearzotti

Spectrofluorometric determination of naproxen in tablets.

P. Damiani, M. Bearzotti, M. Cabezón, 2002, Journal of pharmaceutical and biomedical analysis.

Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome

S. M. Daniele, M. Bearzotti, H. F. Pelusa, 2016, Annals of clinical biochemistry.

Spectrofluorometric determination of ibuprofen in pharmaceutical formulations.

P. Damiani, M. Bearzotti, M. Cabezón, 2001, Journal of pharmaceutical and biomedical analysis.

Spectrofluorometric determination of diclofenac in tablets and ointments.

A. Olivieri, P. Damiani, M. Bearzotti, 1999, Journal of pharmaceutical and biomedical analysis.

Spectrofluorometric determination of piroxicam.

A. Olivieri, P. Damiani, M. Bearzotti, 1998, Journal of pharmaceutical and biomedical analysis.

A test field for the second-order advantage in bilinear least-squares and parallel factor analyses: fluorescence determination of ciprofloxacin in human urine.

A. Olivieri, P. Damiani, M. Bearzotti, 2004, Analytical chemistry.

A validated spectrofluorometric method for the determination of celecoxib in capsules

P. Damiani, M. Bearzotti, M. Cabezón, 2003, Analytical and bioanalytical chemistry.

Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression

R. Cantor, P. Gaffney, E. Soriano, 2013, PLoS genetics.